Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction
- PMID: 339932
- PMCID: PMC1429247
- DOI: 10.1111/j.1365-2125.1978.tb01608.x
Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction
Abstract
1 The effects of atenolol (50 mg and 100 mg) and oxprenolol (80 mg) on respiratory function were studied in ten patients with angina pectoris or hypertension complicated by chronic airways obstruction. 2 In patients with "fixed" airways obstruction, neither atenolol nor exprenolol significantly affected airways resistance. 3 In patients with "labile" airways obstruction, atenolol did not produce a significant increase in airways obstruction, whereas oxprenolol did. 4 Following isoprenaline challenge (1500 microgram by inhalation), atenolol permitted full bronchodilatation, whereas oxprenolol almost completely blocked the action of isoprenaline. 5 Partial agonist activity appears to be of less clinical importance than cardioselectivity.
Similar articles
-
Cardioselectivity of atenolol in asthmatic patients.Eur J Clin Pharmacol. 1981;21(3):173-6. doi: 10.1007/BF00627916. Eur J Clin Pharmacol. 1981. PMID: 7032947 Clinical Trial.
-
Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.Cardiovasc Drugs Ther. 1990 Aug;4(4):1145-9. doi: 10.1007/BF01856511. Cardiovasc Drugs Ther. 1990. PMID: 1982059 Clinical Trial.
-
The effect on HDL cholesterol of oxprenolol and atenolol.Scand J Clin Lab Invest. 1982 Sep;42(5):449-53. Scand J Clin Lab Invest. 1982. PMID: 6130595 Clinical Trial.
-
Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.Drugs. 1979 Jun;17(6):425-60. doi: 10.2165/00003495-197917060-00001. Drugs. 1979. PMID: 38096 Review.
-
Oxprenolol: clinical pharmacology, pharmacokinetics, and pharmacodynamics.Am J Cardiol. 1983 Nov 10;52(9):27D-33D. doi: 10.1016/0002-9149(83)90639-2. Am J Cardiol. 1983. PMID: 6356863 Review.
Cited by
-
Relationship between bronchial effects and plasma practolol concentration in man.Eur J Clin Pharmacol. 1979 Mar 26;15(2):91-6. doi: 10.1007/BF00609870. Eur J Clin Pharmacol. 1979. PMID: 436923 Clinical Trial.
-
Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients.Eur J Clin Pharmacol. 1984;27(2):141-5. doi: 10.1007/BF00544036. Eur J Clin Pharmacol. 1984. PMID: 6149939 Clinical Trial.
-
Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.Br J Clin Pharmacol. 1989 Jul;28(1):95-102. doi: 10.1111/j.1365-2125.1989.tb03510.x. Br J Clin Pharmacol. 1989. PMID: 2570601 Free PMC article. Clinical Trial.
-
A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.Br J Clin Pharmacol. 1986 Nov;22(5):595-602. doi: 10.1111/j.1365-2125.1986.tb02940.x. Br J Clin Pharmacol. 1986. PMID: 2878680 Free PMC article. Clinical Trial.
-
Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease.Br J Clin Pharmacol. 1985 Sep;20(3):205-10. doi: 10.1111/j.1365-2125.1985.tb05062.x. Br J Clin Pharmacol. 1985. PMID: 4041341 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources